» Articles » PMID: 8688974

Papillary Adenoma of Type II Pneumocytes Might Have Malignant Potential

Overview
Journal Virchows Arch
Date 1996 Jun 1
PMID 8688974
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Papillary adenoma of type II pneumocytes is a rare tumour. It is considered to be a benign neoplasm and is derived from immature cells in the bronchioloalveolar epithelium, however, its biological nature has not been elucidated. We report a case of an adenomatous tumour; a papillary adenoma of type II pneumocytes, which we regard as possessing malignant potential. Light microscopically, as well circumscribed, papillary tumour of predominantly cuboidal cells resembling type II pneumocytes was found, but Clara type and ciliated cells were also present. Immunohistochemically, the tumour cells reacted positively with antibodies to surfactant apoproteins (A, B), carcinoembryonic antigen, cytochrome P-450 1A1-2 and 2B1-2. Ultrastructurally, many osmiophilic lamellar bodies and electron-dense granules were demonstrated. Semi-serial sections revealed signs of transbronchial dissemination and vascular invasion. Morphometry using 12-dimensional cluster analysis disclosed features of the tumour cells which resembled those of pneumocyte type II adenocarcinoma. These findings suggest that the present case has some malignant characteristics and originates from immature bronchiolar or alveolar cells, with a potential to develop into both type II pneumocyte and Clara cell type adenocarcinomas.

Citing Articles

Papillary adenoma of the lung: A case report and literature review.

Chen L, Yang M, Gao S, Wang Z, Xu H Exp Ther Med. 2024; 28(3):369.

PMID: 39091411 PMC: 11292175. DOI: 10.3892/etm.2024.12658.


Pulmonary papillary adenoma with malignant potential: a case report and literature review.

Liu P, Feng J, Yang M, Chen J, Fu L, Lu J Diagn Pathol. 2022; 17(1):81.

PMID: 36229884 PMC: 9563795. DOI: 10.1186/s13000-022-01259-8.


Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review.

Liang Z, Zhou P, Wang Y, Zhang Y, Li D, Su X Front Oncol. 2021; 11:667111.

PMID: 34350112 PMC: 8328424. DOI: 10.3389/fonc.2021.667111.


Cytological Features of Pulmonary Papillary Adenoma with Malignant Transformation and Literature Review.

Hu X, Chen Y, Ru G, Yu L Anal Cell Pathol (Amst). 2020; 2020:8827056.

PMID: 33282636 PMC: 7685805. DOI: 10.1155/2020/8827056.


Massive Relief: Papillary Adenoma of the Lung in Asymptomatic Former Smoker Patient.

Stojsic J, Popovic M, Pezzuto F, Markovic J Diagnostics (Basel). 2020; 10(11).

PMID: 33171926 PMC: 7694647. DOI: 10.3390/diagnostics10110906.


References
1.
FINE G, Chang C . Adenoma of type 2 pneumocytes with oncocytic features. Arch Pathol Lab Med. 1991; 115(8):797-801. View

2.
Noguchi M, Kodama T, Shimosato Y, Koide T, NARUKE T, Singh G . Papillary adenoma of type 2 pneumocytes. Am J Surg Pathol. 1986; 10(2):134-9. DOI: 10.1097/00000478-198602000-00006. View

3.
Spencer H, Dail D, Arneaud J . Non-invasive bronchial epithelial papillary tumors. Cancer. 1980; 45(6):1486-97. DOI: 10.1002/1097-0142(19800315)45:6<1486::aid-cncr2820450632>3.0.co;2-h. View

4.
Keith I, Olson Jr E, Wilson N, Jefcoate C . Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450. Cancer Res. 1987; 47(7):1878-82. View

5.
Nomori H, Morinaga S, Kobayashi R, Torikata C . Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system. Virchows Arch. 1994; 424(5):517-23. DOI: 10.1007/BF00191438. View